Work

Recognizing Drug Hypersensitivity in Pigmented Skin

Year: 2022

Type: review

Source: Immunology and Allergy Clinics of North America

DOI: 10.1016/j.iac.2022.01.005

Authors: Rannakoe J. Lehloenya, Elizabeth J. Phillips, Helena B. Pasieka, Jonny Peter

Institutions: University of Cape Town, Groote Schuur Hospital, Murdoch University, Vanderbilt University Medical Center, MedStar Washington Hospital Center, Uniformed Services University of the Health Sciences, Georgetown University, MedStar Georgetown University Hospital

Language: English

Topic: Drug-Induced Adverse Reactions

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, Fogarty International Center

Awards: Improving Prediction of Drug Action, IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study), Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors, Single Cell definition of pathogenic T cells in Drug-induced Stevens-Johnson-Syndrome/Toxic epidermal necrolysis, Immune-mediated adverse drug reactions to HIV and TB treatments in South Africa: predict, prevent and improve long-term outcomes (IMARI SA study), HIV-associated Tuberculosis Training Program (HATTP), NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

OpenAlex ID: W4220746437

FWCI: 0.502

Cites: 66

Cited by: 15

Related to: 10